Dual-target, High-dose TMS for PD Patients With FOG
A legfontosabb adatok
- Ki végzi
- Anhui Medical University
- Hol
- Kína1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Leállítva
- Résztvevők
- 64 fő vett részt
- Kezdés
- 2022. dec. 22.
- Befejezés
- 2024. márc. 31.
- A vizsgálat típusa
- Beavatkozással járó, 3 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- transcranial magnetic stimulation
- A regiszteradat frissítve
- 2025. november 19.
- Miért állt le
- The study was halted at the midpoint because the interim analysis demonstrated a large effect size of the DHT group compared with the SCT group (Cohen's d = 1.58).
Ki vehet részt
- Életkor
- 40 év – 85 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 11 feltétel megnézéseKevesebb
Ki vehet részt
- diagnosis of FOG with expertise in movement disorders
- the score of item 3 of the FOG questionnaire ≥1
- ongoing treatment with a stable dose of any medication for 2 months
- 40 years of age or older
Ki nem vehet részt
- anti-PD medication adjustments during rTMS treatment
- previously received rTMS treatment
- prior history of seizure or history in first-degree relatives
- a history of addiction, psychiatric disorders, or neurological diseases other than PD
- history of substance abuse within the past 6 months
- focal brain lesions on T1-/T2-weighted fluid-attenuated inversion recovery images
- nonremovable metal objects in or around the head
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The aim of the current study was to verify whether high-dose TMS treatment of the motor and cognitive cortices is more effective in alleviating FOG than conventional-dose TMS of the motor cortex only. Specifically, investigator hypothesized that the effect of dual-target TMS on FOG is better than traditional stimulation of the motor cortex only, and the effect of high-dose TMS is better than conventional doses.
A vizsgálat 3 csoportja
- Dual-target high-dose TMS (DHT)A vizsgált kezelés
DHT refers to the left primary motor cortex of the lower leg (M1) and dorsolateral prefrontal cortex (DLPFC) receiving 9000 pulses/day of intermittent TBS (iTBS) for 5 consecutive days. Each iTBS sequence in the high-dose stimulation sequence released 900 pulses at a time with a pulse cluster repeated every 200 ms at a frequency of 5 Hz. Each pulse cluster contained three pulses with a frequency of 50 Hz, stimulation time of 2 s, and interval of 8 s. A total of 10 iTBS sessions was performed each day with an interval of 40 min and the daily stimulation dose was 9000 pulses. The order of stimulation for the two targets was randomized across participants and the order of stimulation within participants remained unchanged throughout the session.
Kezelés: transcranial magnetic stimulation
- Dual-target conventional-dose TMS (DCT)A vizsgált kezelés
DCT refers to the left M1 and DLPFC receiving 1800 pulses/day of iTBS for 5 consecutive days. Each iTBS sequence in the conventional-dose stimulation sequence released 600 pulses at a time with a pulse cluster repeated every 200 ms at a frequency of 5 Hz. Each pulse cluster contained three pulses with a frequency of 50 Hz, stimulation time of 2 s, and interval of 8 s. A total of three iTBS sessions were performed each day with an interval of 40 min and the daily stimulation dose was 1800 pulses.The order of stimulation for the two targets was randomized across participants and the order of stimulation within participants remained unchanged throughout the session.
Kezelés: transcranial magnetic stimulation
- Single-target conventional-dose TMS (SCT)Már használt kezelés, összehasonlításként
SCT refers to the left M1 receiving 1800 pulses/day of iTBS treatment for 5 consecutive days. Each iTBS sequence in the conventional-dose stimulation sequence released 600 pulses at a time with a pulse cluster repeated every 200 ms at a frequency of 5 Hz. Each pulse cluster contained three pulses with a frequency of 50 Hz, stimulation time of 2 s, and interval of 8 s. A total of three iTBS sessions were performed each day with an interval of 40 min and the daily stimulation dose was 1800 pulses.
Kezelés: transcranial magnetic stimulation
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Dual-target, High-dose, Transcranial Magnetic Stimulation for Parkinson's Disease With Freezing of Gait
- A regiszteradat frissítve
- 2025. november 19.